## BRO: Brown & Brown, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -1.4% below STRENGTH zone (4.0-10.0%); PEG 4.41 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($76.26)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Brown & Brown Employer Health and Benefits Strategy Survey | 2026 Edition**
- Source: Brown & Brown | 20251201T190628 | Neutral | Relevance: 99%
- Brown & Brown's second annual Employer Health and Benefits Strategy Survey for 2026 highlights rising costs, evolving workforce needs, and a focus on innovation and sustainability as key shapers of the benefits landscape. The survey, which included 1,241 employers, found a shift in strategic priorities, with cost control now topping the list for both employees and employers. Attracting and retaining a healthy and engaged workforce, previously the top priority, moved to third place.

**2. Q3 Results Fail to Shift Barclays’ Equal Weight Rating on Brown & Brown (BRO)**
- Source: Insider Monkey | 20251202T080600 | Somewhat-Bullish | Relevance: 99%
- Barclays maintained its Equal Weight rating on Brown & Brown (BRO) despite the company reporting robust Q3 2025 revenues of $1.6 billion, a 35% growth year-over-year, and a 170 basis point expansion in its EBITDAC margin. The firm lowered its price target to $84 from $102. Brown & Brown also announced a 10% dividend increase, marking 32 consecutive years of growth, and an expansion of its share repurchase program to $1.5 billion.

**3. Quadrature Capital Ltd Makes New Investment in Brown & Brown, Inc. $BRO**
- Source: MarketBeat | 20251201T113615 | Somewhat-Bullish | Relevance: 99%
- Quadrature Capital Ltd has made a new investment in Brown & Brown, Inc. (NYSE:BRO) during Q2, purchasing 14,746 shares valued at approximately $1.635 million. Institutional investors now own about 71.01% of the stock. The company recently exceeded quarterly earnings estimates and raised its dividend, though analyst ratings are mixed with an average "Hold" rating.

**4. Q3 Results Fail to Shift Barclays’ Equal Weight Rating on Brown & Brown (BRO)**
- Source: Yahoo Finance | 20251202T130600 | Somewhat-Bullish | Relevance: 99%
- Barclays has maintained its Equal Weight rating on Brown & Brown (BRO) despite the company's strong Q3 2025 results, which included significant revenue growth and an increased EBITDAC margin. The firm lowered its price target for BRO from $102 to $84. Brown & Brown also announced a dividend increase and an expansion of its share repurchase program, demonstrating a commitment to shareholder value.

**5. Brown & Brown, Inc. (NYSE:BRO) Receives Consensus Rating of "Hold" from Brokerages**
- Source: MarketBeat | 20251130T063608 | Neutral | Relevance: 99%
- Brown & Brown, Inc. (NYSE:BRO) has received a consensus "Hold" rating from seventeen brokerages, with an average 12-month price target of $102.69 despite recent target cuts from multiple analysts. The company reported strong Q3 earnings, beating EPS estimates and showing significant revenue growth, alongside increased institutional buying and a raised quarterly dividend.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Barclays | $84 | $102 | -18% |
| 2025-11-17 | Morgan Stanley | $85 | $95 | -11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Barclays | main | Equal-Weight |
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.9% (+4.8%)
- Blackrock Inc.: 6.1% (+2.2%)
- Capital World Invest: 5.1% (+81.1%)
- Principal Financial : 4.5% (+13.4%)
- State Street Corpora: 3.8% (+5.3%)

### Key Risks

1. Valuation stretched: PEG 4.4x requires aggressive growth execution.
2. Long-term trend broken: trading 22.1% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.41 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Revenue growth strong at 23% YoY. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.5B |
| Beta | 0.81 |
| 52W Range | $76.17 - $125.68 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.41 |
| Forward P/E | 17.1 |
| Current P/E | 18.8 |
| YoY Growth | 9.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.7% to -1.4% (-3.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.5pp (needs >4.0% for momentum thesis). Below SMA200 (0.78x), long-term trend not supportive. MACD histogram positive (0.56), confirming momentum. RSI neutral at 42.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.45% (CS: 41) | Neutral |
| RSI_14 | 41.7 | Neutral |
| MACD Histogram | 0.56 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 0.929x | Below |
| vs SMA200 | 0.779x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $79.84
- **Stop Loss:** $76.26 (4.5% risk)
- **Target:** $83.42 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 139
- **Position Value:** $11,097.76
- **Portfolio %:** 11.10%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-26 (Est: $0.90)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.93 | $1.05 | +12.9% |
| 2025Q2 | $0.99 | $1.03 | +4.6% |
| 2025Q1 | $1.30 | $1.29 | -0.5% |
| 2024Q4 | $0.77 | $0.86 | +12.1% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*